home page

Management Team

Lawrence Bloch, MD, JD, Chief Executive Officer and President
John S. Andrews, PhD, Chief Scientific Officer
Robert A. Medve, MD, Chief Medical and Regulatory Officer
Suman Rakhit, PhD, Executive Vice President of Chemistry
Tom Lategan DPhil, Vice President of Regulatory Affairs
Shawn Maddaford, PhD, Vice President of Discovery Chemistry

Leadership

Management Team
Board of Directors
Board Observers
Scientific Advisory Board



Tom Lategan DPhil, Vice President of Regulatory Affairs

Dr Lategan has over 20 years of experience in pharmaceutical regulatory strategy with Actelion, The Medicines Company, Roche, and was most recently Vice President of Regulatory Affairs at Panacos. He has a successful drug development history including Tracleer, Zavesca, Angiomax and Aurorix and earned his doctorate in Pharmacology from the University of Oxford.

Home | NeurAxon | Market | Pipeline | Research | News | Contact